Compounds, compositions and methods are provided for modulating the
expression of kallikrein 6. The compositions comprise oligonucleotides,
targeted to nucleic acid encoding kallikrein 6. Methods of using these
compounds for modulation of kallikrein 6 expression and for diagnosis and
treatment of disease associated with expression of kallikrein 6 are
provided.